Global Program Head News Today

Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Digi-Tech Pharma & AI 2024" conference has been added to ResearchAndMarkets.com's offering. The 7th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry. Meet the decision makers, benchmark and learn from real-life use cases to drive ...

CRISPR Therapeutics announced the appointment of Naimish Patel, M.D., as Chief Medical Officer, effective May 28, 2024. Dr. Patel is an experienced drug developer who has worked across a wide range of...

WILMINGTON, Del.--(BUSINESS WIRE)--Oct 13, 2023--

AUSTIN, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...

AUSTIN, Texas, Sept. 28, 2023 -- Molecular Templates, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology with potent differentiated mechanisms of action,...

Results from open-label extension period of the Phase 2 trial demonstrate that longer-term treatment with povorcitinib 75 mg resulted in sustained and durable efficacy across all treatment arms Data

Board expansion brings significant additional gene therapy and corporate development expertise to AnjariumZURICH, Oct. 18, 2022 /PRNewswire/ -- Anjarium Biosciences AG ("Anjarium"), a biotech

- Former Novartis ophthalmology program head significantly strengthens Dopavision´s management capabilities- Company recently initiated clinical trial of...

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--Feb 1, 2022--

Biopharma companies and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.